BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Vinod B. Shidham. Textbook of Gastrointestinal Oncology2019; : 13 doi: 10.1007/978-3-030-18890-0_2
2
Chyou-Wei Wei, Pei-Lun Chou, Yu-Ting Hung, Giou-Teng Yiang. Synergistic cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and Rana catesbeiana ribonuclease-6 in hepatoma cellsTzu Chi Medical Journal 2011; 23(1): 9 doi: 10.1016/j.tcmj.2011.03.002
3
Yusuke Yamamoto, Hisashi Ikoma, Ryo Morimura, Katsutoshi Shoda, Hirotaka Konishi, Yasutoshi Murayama, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Takeshi Kubota, Masayoshi Nakanishi, Daisuke Ichikawa, Hitoshi Fujiwara, Kazuma Okamoto, Chouhei Sakakura, Toshiya Ochiai, Eigo Otsuji. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosisWorld Journal of Gastroenterology 2015; 21(1): 246-253 doi: 10.3748/wjg.v21.i1.246
4
Ye Xin Koh, Hwee Leong Tan, Weng Kit Lye, Juinn Huar Kam, Adrian Kah Heng Chiow, Siong San Tan, Su Pin Choo, Alexander Yaw Fui Chung, Brian Kim Poh Goh. Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidenceWorld Journal of Hepatology 2018; 10(6): 433-447 doi: 10.4254/wjh.v10.i6.433
5
Francesco Vasuri, Rita Golfieri, Michelangelo Fiorentino, Elisa Capizzi, Matteo Renzulli, Antonio D. Pinna, Walter F. Grigioni, Antonia D’Errico-Grigioni. OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantationVirchows Archiv 2011; 459(2): 141 doi: 10.1007/s00428-011-1099-5
6
Cheng-Mei Chen, Chien-Yeh Hsu, Chyi-Huey Bai. Building a Patient Oriented Treatment Decision System for Liver Cancer2012 Third Global Congress on Intelligent Systems 2012; : 413 doi: 10.1109/GCIS.2012.11
7
Thuingaren Sareo, Yumkhaibam S. Devi, Laishram J. Singh. Hepatocellular carcinoma in situs inversus totalis-a case reportMedical Journal of Indonesia 2014; : 48 doi: 10.13181/mji.v23i1.690
8
Qing-Qiang Shi, Guo-Wei Zuo, Zi-Qiang Feng, Lv-Cui Zhao, Lian Luo, Zhi-Mei You, Dang-Yang Li, Jing Xia, Jing Li, Di-Long Chen. Effect of Trichostatin A on Anti HepG2 Liver Carcinoma Cells: Inhibition of HDAC Activity and Activation of Wnt/β-Catenin SignalingAsian Pacific Journal of Cancer Prevention 2014; 15(18): 7849 doi: 10.7314/APJCP.2014.15.18.7849
9
Kwong-Ming Kee, Jing-Houng Wang, Chih-Yun Lin, Chih-Chi Wang, Yu-Fan Cheng, Sheng-Nan Lu. Validation of the 7th Edition TNM Staging System for Hepatocellular Carcinoma: An Analysis of 8,828 Patients in a Single Medical CenterDigestive Diseases and Sciences 2013; 58(9): 2721 doi: 10.1007/s10620-013-2716-8
10
Kai Wang, Susumu Eguchi, Masaaki Hidaka, Tao Jin, Akihiko Soyama, Tamotsu Kuroki, Mingwen Huang, Linquan Wu, Shubing Zou, Jianghua Shao. Comparison of the outcomes of hepatocellular carcinoma after hepatectomy between two regional medical centers in China and JapanAsian Journal of Surgery 2017; 40(5): 380 doi: 10.1016/j.asjsur.2016.03.002
11
Rajan B. Patel, Natvar R. Gupta, Nitin C. Vasava, Janak R. Khambholja, Sanjay Chauhan, Amit Desai. Situs Inversus Totalis (SIT) with Hepatocellular Carcinoma (HCC): A Rare Case Report and Review of 12 Other CasesIndian Journal of Surgery 2013; 75(6): 424 doi: 10.1007/s12262-012-0744-9
12
Yu-Pei Liao, Pei-Tseng Kung, Yueh-Hsin Wang, Yeong-Ruey Chu, Shung-Te Kao, Wen-Chen Tsai. Effects and Relative Factors of Adjunctive Chinese Medicine Therapy on Survival of Hepatocellular Carcinoma Patients: A Retrospective Cohort Study in TaiwanIntegrative Cancer Therapies 2020; 19: 153473542091527 doi: 10.1177/1534735420915275
13
Chih H Cheng, Chen F Lee, Tsung H Wu, Kun M Chan, Hong S Chou, Ting J Wu, Ming C Yu, Tse C Chen, Wei C Lee, Miin F Chen. Evaluation of the new AJCC staging system for resectable hepatocellular carcinomaWorld Journal of Surgical Oncology 2011; 9(1): 114 doi: 10.1186/1477-7819-9-114
14
Qingqiang Shi, Xueping Shi, Gei Zuo, Wei Xiong, Haixing Li, Pei Guo, Fen Wang, Yi Chen, Jing Li, Di-Long Chen. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-cateninOncology Reports 2016; 36(4): 2059 doi: 10.3892/or.2016.5033